{
    "Project Title": "Not Available",
    "Sponsor": "Sanofi Group",
    "Study Number": "GZ402673-EFC13429",
    "Protocol Version and Date": "Version number: 1, 15-Dec-2021",
    "Study Title": "Protocol No. 05: alemtuzumab",
    "Phase": "Not Available",
    "Therapeutic Area": "Multiple Sclerosis",
    "Number of Patients": "At least 60",
    "Number of Sites": "Not Available",
    "Indication": "Not Available",
    "Duration of Treatment": "Approximately 2 years",
    "Schedule of Assessments": "Table 2 - Schedule of events in Year 2",
    "questionnaires": [
        {
            "longName": "Expanded Disability Status Scale",
            "shortName": "EDSS",
            "type": "ClinRO",
            "questionnaireSchedule": "Screening, D-7, M4, M8, M12, M15, M18, M21, M24/at EOTP; every 6 months in Safety Monitoring Phase, and at every relapse visit.",
            "questionnaireTiming": [
                "Visit Daya: M30",
                "Visit Daya: b  M36",
                "Visit Daya: Relapse Visit",
                "Visit Daya: M15",
                "Visit Daya: M18",
                "Visit Daya: M21",
                "Visit Daya: M24 (EOTP)",
                "Visit Daya: Relapse Visit  b"
            ]
        },
        {
            "longName": "Symbol Digit Modality Test",
            "shortName": "SDMT",
            "type": "PRO",
            "questionnaireSchedule": "X at multiple visit points: M0, M1, M2, M3, M4, M8, M12, M16.",
            "questionnaireTiming": [
                "Visit Daya: b  M36",
                "Visit Daya: M18",
                "Visit Daya: M24 (EOTP)"
            ]
        },
        {
            "longName": "Brief Visuospatial Memory Test - Revised",
            "shortName": "BVMT-R",
            "type": "PRO",
            "questionnaireSchedule": "X at multiple visit points: M0, M1, M2, M3, M4, M8, M12, M16.",
            "questionnaireTiming": [
                "Visit Daya: b  M36",
                "Visit Daya: M18",
                "Visit Daya: M24 (EOTP)"
            ]
        },
        {
            "longName": "Pediatric Quality of Life Inventory",
            "shortName": "PedsQL",
            "type": "PRO",
            "questionnaireSchedule": "X at multiple visit points: M0, M1, M4, M12.",
            "questionnaireTiming": [
                "Visit Daya: M30",
                "Visit Daya: b  M36",
                "Visit Daya: Relapse Visit",
                "Visit Daya: M15",
                "Visit Daya: M18",
                "Visit Daya: M21",
                "Visit Daya: M24 (EOTP)",
                "Visit Daya: Relapse Visit  b"
            ]
        },
        {
            "longName": "Pediatric Neuro-QoL",
            "shortName": "Peds NeuroQoL",
            "type": "PRO",
            "questionnaireSchedule": "X at multiple visit points: M0, M1, M4, M12.",
            "questionnaireTiming": [
                "Visit Daya: b  M36"
            ]
        },
        {
            "longName": "Tanner Staging",
            "shortName": "Tanner",
            "type": "ClinRO",
            "questionnaireSchedule": "Screening, M12, M24/at EOTP; annually in the safety monitoring phase.",
            "questionnaireTiming": [
                "Visit Daya: b  M36",
                "Visit Daya: M24 (EOTP)"
            ]
        }
    ]
}